Overview

A Multicenter, Randomized, Double Blind, Double Dummy, Parallel-Group Efficacy Study Comparing 8 Weeks of Treatment With Esomeprazole Magnesium (40mg qd) to Lansoprazole (30mg qd) for the Healing of Erosive Esophagitis in Patients With Moderate or S

Status:
Completed
Trial end date:
2003-08-01
Target enrollment:
Participant gender:
Summary
This study looks at the healing rates in patients with Erosive Esophagitis (EE) when treated with either esomeprazole or lansoprazole
Phase:
Phase 4
Details
Lead Sponsor:
AstraZeneca
Treatments:
Dexlansoprazole
Esomeprazole
Lansoprazole